Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy

Our data suggests that miR-208b is involved in the remodeling process and pathogenesis of DCM by post-transcriptional gene expression modulation. MicroRNA-208b might be a novel therapeutic target for DCM.